scholarly journals Liposuction of Breast Cancer-Related Arm Lymphedema Reduces Fat and Muscle Hypertrophy

2021 ◽  
Author(s):  
Tobias Karlsson ◽  
Magnus Karlsson ◽  
Karin Ohlin ◽  
Gaby Olsson ◽  
Håkan Brorson
Keyword(s):  
Breast Cancer ◽  
Muscle Hypertrophy ◽  
Arm Lymphedema

scholarly journals Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kayo Togawa ◽  
Huiyan Ma ◽  
Ashley Wilder Smith ◽  
Marian L. Neuhouser ◽  
Stephanie M. George ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Physical Health ◽  
Analysis Of Covariance ◽  
Health Related Quality ◽  
Burning Pain ◽  
Related Quality ◽  
Health Related ◽  
Arm Lymphedema

AbstractWe examined cross-sectional associations between arm lymphedema symptoms and health-related quality of life (HRQoL) in the Health, Eating, Activity and Lifestyle (HEAL) Study. 499 women diagnosed with localized or regional breast cancer at ages 35–64 years completed a survey, on average 40 months after diagnosis, querying presence of lymphedema, nine lymphedema-related symptoms, e.g., tension, burning pain, mobility loss, and warmth/redness, and HRQoL. Analysis of covariance models were used to assess HRQoL scores in relation to presence of lymphedema and lymphedema-related symptoms. Lymphedema was self-reported by 137 women, of whom 98 were experiencing lymphedema at the time of the assessment. The most common symptoms were heaviness (52%), numbness (47%), and tightness (45%). Perceived physical health was worse for women reporting past or current lymphedema than those reporting no lymphedema (P-value < 0.0001). No difference was observed for perceived mental health (P-value = 0.31). Perceived physical health, stress, and lymphedema-specific HRQoL scores worsened as number of symptoms increased (P-values ≤ 0.01). Women reporting tension in the arm had lower physical health (P-value = 0.01), and those experiencing burning pain, tension, heaviness, or warmth/redness in the arm had lower lymphedema-specific HRQoL (P-values < 0.05). Treatment targeting specific lymphedema-related symptoms in addition to size/volume reduction may improve some aspects of HRQoL among affected women.

Weight loss does not decrease risk of breast cancer–related arm lymphedema

Cancer ◽  
2021 ◽  
Author(s):  
Sacha A. Roberts ◽  
Tessa C. Gillespie ◽  
Amy M. Shui ◽  
Cheryl L. Brunelle ◽  
Kayla M. Daniell ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Weight Loss ◽  
Arm Lymphedema

Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors

2015 ◽  
Vol 9 (3) ◽  
pp. 422-430 ◽  
Author(s):  
Nandita Das ◽  
Richard N. Baumgartner ◽  
Elizabeth C. Riley ◽  
Christina M. Pinkston ◽  
Dongyan Yang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Related Risk ◽  
Arm Lymphedema

scholarly journals Arm lymphedema after treatment of breast cancer: Etiology, diagnosis, and management

2015 ◽  
Vol 01 (02) ◽  
pp. 077-083 ◽  
Author(s):  
Ashish Goel ◽  
Juhi Agarwal ◽  
Sandeep Mehta ◽  
Kapil Kumar
Keyword(s):  
Breast Cancer ◽  
Solid Phase ◽  
Subcutaneous Tissue ◽  
Fluid Phase ◽  
Team Work ◽  
Treatment Modalities ◽  
Cancer Etiology ◽  
Complete Decongestive Therapy ◽  
Arm Lymphedema ◽  
Decongestive Therapy

ABSTRACTBreast cancer related lymphedema (BCRL) is a chronic debilitating condition seen after treatment of breast cancer. The overall incidence varies from 20% to 56% in all patients treated for breast cancer. Every patient is at a lifelong risk for BCRL and the risk goes on increasing as the followup period increases. Locoregional treatment including surgery or radiotherapy is the most common risk factor for development of arm lymphedema. There are two phases of arm lymphedema. There is increased fluid accumulation in the fluid phase of lymphedema which later on goes into the solid phase where fat and fibrotic tissue is deposited in the subcutaneous tissue. The treatment of BCRL is a challenge both for the patient and the treating surgeon and it needs multidisciplinary team work to be successful. Non-surgical treatment modalities include complete decongestive therapy (CDT) and pneumatic compression therapy. Surgery for BCRL is usually undertaken as a salvage modality after failure of conservative approaches. The surgical spectrum for BCRL varies from extensive excisional operations which were commonly done in the past to newer methods like suction assisted protein lipectomy, lymphatic reconstruction and vascular lymph node transfer (VLNT) using super-microsurgical techniques. There is no consensus regarding the preference of one procedure over other due to lack of randomised control trials. It is however suggested to do lymphovenous anastomosis and complete decongestive therapy for early cases in fluid phase; while patients in the solid phase may be treated with a combination of liposuction with CDT or VLNT alone.

scholarly journals Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
María Nieves Muñoz-Alcaraz ◽  
Luis Ángel Pérula-de-Torres ◽  
Jesús Serrano-Merino ◽  
Antonio José Jiménez-Vílchez ◽  
María Victoria Olmo-Carmona ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Group Intervention ◽  
Skin Care ◽  
Stage I ◽  
Current Evidence ◽  
Link Type ◽  
Proprioceptive Neuromuscular Facilitation ◽  
Arm Lymphedema

Abstract Background Breast cancer (BC) is a major public health issue. More than one out of five women treated for breast cancer will develop lymphedema in an upper extremity. Current evidence advocates transdisciplinary oncological rehabilitation. Therefore, research in this area is necessary since limited consensus having been reached with regard to the basic essential components of this rehabilitation. Consensus has, however, been reached on the use of decongestive lymphedema therapy (DLT), but due to a lack of tests, the necessary dosages are unknown and its level is moderately strong. This study attempts to verify both the efficacy of activity-oriented proprioceptive antiedema therapy (TAPA), as compared to conventional treatments such as DLT or Complex Physical Therapy (CPT), as well as its efficiency in terms of cost-effectiveness, for patients affected by breast cancer-related arm lymphedema. Methods Controlled, randomized clinical trial with dual stratification, two parallel arms, longitudinal and single blind. 64 women with breast cancer-related arm lymphedema will take part in the study. The experimental group intervention will be the same for stage I and II, and will consist of neuro-dynamic exercises oriented to the activity, proprioceptive neuromuscular facilitation activities and proprioceptive anti-edema bandaging. The control group intervention, depending on the stage, will consist of preventive measures, skin care and exercise-prescribed training in the lymphedema workshop as well as compression garments (Stage I) or conservative Complex Decongestive Therapy treatment (skin care, multi-layer bandaging, manual lymphatic drainage and massage therapy) (Stage II). Results Sociodemographic and clinical variables will be collected for the measurement of edema volume and ADL performance. Statistical analysis will be performed on intent to treat. Discussion It has been recommended that patient training be added to DLT, as well as a re-designing of patient lifestyles and the promotion of health-related aspects. In addition, clinical trials should be undertaken to assess neural mobilization techniques and proprioceptive neuromuscular facilitation should be included in the therapy. Cohesive bandaging will also be performed as an early form of pressotherapy. The proposed study combines all of these aspects in order to increased comfort and promote the participation of individuals with lymphedema in everyday situations. Limitations The authors have proposed the assessment of the experimental treatment for stages I and II. One possible limitation is the lack of awareness of whether or not this treatment would be effective for other stages as well as the concern for proper hand cleansing during use of bandages, given the current COVID-19 pandemic situation. Trial registration This trial was registered in ClinicalTrials.gov (NCT03762044). Date of registration: 23 November 2018. Prospectively Registered.

Sign in / Sign up

Export Citation Format

Share Document